Navigation Links
Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients
Date:11/6/2008

LONDON and NEW YORK, Nov. 6 /PRNewswire/ -- Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, today announced positive data from its ICH compliant Phase II equivalent multi-center study of MRX-4 (n=105) in patients suffering from allergic rhinitis. MRX-4 was given as an intranasal spray formulation.

The Nasal Allergen Challenge (NAC) study was conducted in allergic rhinitis patients outside of the local allergy season. MRX-4 was compared with both placebo (Arm 1) and an intranasal steroid Rhinocort(R) (as a positive control, Arm 2). Arm 1 of the study consisted of a six-day, twice-daily intranasal administration of placebo or MRX-4 followed by an intranasal dose of allergen on the morning of the seventh day with a clinical follow-up and scoring over the next 24 hours. Blood, urine and pharmacokinetics (PK) analyses were also conducted.

MRX-4 efficacy was assessed by its reduction of six clinical categories: rhinorrhea, nasal itching, sneezing, frontal headache, nasal congestion and ear/palate itching. Multivariate analysis (chi-test) demonstrated a statistically significant (p < 0.01) therapeutic effect versus placebo. In addition, no serious adverse effects (SAEs) were noted and the drug was not detected in patients' serum (PK).

"The clinical data demonstrates that MRX-4 has a statistically significant effect on several key symptom categories of allergic rhinitis: it correlates nicely with the nasal lavage inflammatory marker data," said Morria president, Yuval Cohen. "This is a potent indication that MRX-4 functions as an intra-nasal anti-inflammatory drug for allergic rhinitis."

Morria recently reported the positive results regarding MRX-4 modulating the levels of inflammatory mediators (IL-5, IL-13, MCP-1, TNF-alpha and Eotoxin) as well as eosinophils in the nasal lavage from the same study.

"The results of the ICH compliant Phase II equivalent study represent a signifi
'/>"/>

SOURCE Morria Biopharmaceuticals Plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Morria Biopharmaceuticals Plc to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
2. Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds
3. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
4. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
5. Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period
6. Nomad Bioscience: New Plant Biotechnology Company Founded to Focus on Biomaterials and Biopharmaceuticals
7. Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants
8. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
10. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
11. XTL Biopharmaceuticals Announces Appointment of Laurence N. Charney to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... 3 JourneyLite of Houston, LLC announced ... patients a second surgical option, vertical sleeve gastrectomy ... it currently performs. The first sleeve gastrectomy procedure at ... St. Laurent, MD on October 20, 2009. The ...
(Date:12/3/2009)... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it ... fiscal year 2010 on December 10, 2009 at 7:00 a.m. ... discuss the results at 11:30 a.m. EST on the same ... the second quarter ended October 31, 2009 and will review ...
(Date:12/2/2009)... Philippines, Dec. 2 Spectrum Blue Steel is emerging as ... planet. Through the efforts of True Green Energy Group and ... has been in the recycling business for over 25 years, ... everyone and is setting the stage for spectacular earnings because ...
(Date:12/2/2009)... first concept demonstration tires made with BioIsoprene ... ingredient in the manufacture of synthetic rubber with renewable ... One tire will be on display at a lounge ... Airport throughout December 21, while the other tire will ...
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
... 9 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX:,ARI), a ... of,antibody therapeutics, today announced that RiskMetrics ISS Canada,Canada,s ... have no,objection to the transaction, and are recommending ... proposed plan of arrangement whereby Roche,will acquire all ...
... CORDOVA, Calif., Sept. 9 ThermoGenesis,Corp. (Nasdaq: ... and,services that process and store adult stem cells, ... fiscal 2008 more than doubled over the same ... today that it has signed,a distribution agreement with ...
... 9 For the second consecutive,year, MedNet Solutions, ... management systems, has been recognized by,Inc. magazine as ... With consistently strong growth over the past four ... the Twin Cities,metro area, and fifth among healthcare-related ...
Other Biology Technology:Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche 2Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche 3ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 2ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 3ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 4ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 5ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 6ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 7ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 8ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent 9MedNet Solutions Again Recognized as one of the Fastest Growing US Companies 2
(Date:12/5/2009)... exhaustive research into venom produced by snakes and spiders, ... a mystery. Now, a study of 158 catfish species, ... Biology , has catalogued the presence of venom glands ... Wright, from the University of Michigan, USA, carried out ... techniques to elucidate the diversity and distribution of venomous ...
(Date:12/4/2009)... the Royal Botanic Gardens, Kew and the Natural History ... more widespread than previously thought, with many commonly grown ... way to being "meat eaters". A review paper, Murderous ... carnivory, is published today (4 December 2009) in the ...
(Date:12/3/2009)... BIO-key International, Inc. (OTC Bulletin Board: BKYI), ... biometric identification solutions, announced that a majority of ... today approved the sale of the company,s Law ... the shares voted, 98.6% were cast in favor ...
Breaking Biology News(10 mins):Scientists think 'killer petunias' should join the ranks of carnivorous plants 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 1The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 2PSE 26G Childrens Specialized Hospital and New York Giants Team Up to Offer Text to Donate Campaign 56867 1PSE 26G Childrens Specialized Hospital and New York Giants Team Up to Offer Text to Donate Campaign 56867 2UnisourceDirect 26amp 3B 238482 3B Web Site Now Offering Products to Maintain a Healthy School Environment 56865 1UnisourceDirect 26amp 3B 238482 3B Web Site Now Offering Products to Maintain a Healthy School Environment 56865 2UnisourceDirect 26amp 3B 238482 3B Web Site Now Offering Products to Maintain a Healthy School Environment 56865 3
... SALT LAKE CITYResearchers have discovered two enzymes that, when ... cancer. Manipulating these enzymes genetically might lead to targeted ... tumors. , "We could conceivably reactivate a completely normal ... could prevent the growth of a tumor if reactivated," ...
... caribou are also central to the health and vitality of ... soon become endangered ,by threats such as oil exploration and ... the Wildlife Conservation Society and the World Wildlife Fund. ... Press Toronto, $50/29.00), the book highlights the caribou in terms ...
... in eastern Burma (also known as Myanmar) are widespread ... Johns Hopkins Bloomberg School of Public Health. The researchers ... a home delivery during their last pregnancy and displaced ... receive no antenatal care. Human rights violations, like displacement ...
Other Biology News:Newly found enzymes may play early role in cancer 2Rudolf's kin more than just Santa's ride 2Rudolf's kin more than just Santa's ride 3Maternal health problems in Myanmar widespread 2
Rabbit polyclonal to Peptide E ( Abpromise for all tested applications)....
... Custom Synthesis Service provides you ... to knockdown any gene. We ... base pairs with terminal dT ... other lengths of your choice. ...
... the first fully genetically encoded fluorescent sensor ... hydrogen peroxide (H2O2), one of the main ... basis of yellow fluorescent protein inserted into ... OxyR (OxyR-RD), HyPer demonstrates submicromolar affinity to ...
Alexa Fluor 647 anti-mouse Qa-2...
Biology Products: